2018
18/12/2018
BioSpectrum Asia – Diabetic kidney disease could overwhelm our health systems
26/11/2018
Proteomics signs PromarkerD agreement with US big pharma
09/11/2018
PromarkerD kit version complete – Commercial release imminent
31/10/2018
Proteomics International is at AusBiotech: 31st October to 2nd November 2018
31/10/2018
October Newsletter 2018
27/10/2018
Proteomics wins WA Export Award 2018
24/10/2018
Diabetic kidney disease test enters Europe & Export Award
17/10/2018
Proteomics receives $834k in R&D Tax Incentive
05/10/2018
Proteomics receives $928k from sale of shareholding in CPR
19/09/2018
Proteomics & Atturos partner to target diagnostics in Europe
18/09/2018
Proactive Investors Australia – Proteomics International Laboratories boosts balance sheet with sale of CPR Pharma Services stake
17/09/2018
Proteomics International India Trade Visit: 24th – 28th September 2018
12/09/2018
Proteomics to receive $928k from sale of shareholding in CPR
08/09/2018
The Australian Financial Review – PromarkerD Australian-developed blood test could help for 30 million diabetics
07/09/2018
The Australian – Australian-developed blood test could help 30 million American diabetics
07/09/2018
SBS News – Diabetes sufferers could soon predict whether their kidney will deteriorate following an Australian company’s launch of a diagnostic test in the US market.
29/08/2018
2018 Annual Report
23/08/2018
Diagnostics Update – the Promarker pipeline
03/08/2018
Proteomics on Bulls, Bears & Brokers
31/07/2018
July Newsletter 2018
17/07/2018
Proteomics secures major contract – nears cash flow positive
22/06/2018
Proteomics at ADA Diabetes Conference
20/06/2018
Proteomics signs deal with Patia for PromarkerD in Mexico
30/05/2018
Australian R&D Tax Incentive Customer Stories – Proteomics International- Saving lives through new predictive diagnostic tests
29/05/2018
MTP Connect – Proteomics International signs deal with PrismHealthDx to launch PromarkerD predictive test for diabetic kidney disease in USA
29/05/2018
medianet – Proteomics International signs deal with PrismHealthDx to launch PromarkerD predictive test for diabetic kidney disease in USA
29/05/2018
SmallCaps – Proteomics’ predictive diabetes test to be sold in US and could soon be coming to Australia
29/05/2018
Proteomics International signs deal to launch PromarkerD test for diabetic kidney disease in USA
11/05/2018
Proteomics on SkyBusiness
09/05/2018
Proteomics on the Radio
27/04/2018
April Newsletter 2018
19/04/2018
Europe PromarkerD patent granted for diabetic kidney disease
06/04/2018
Conversion of 90% of Proteomics Options raises of $3m
20/03/2018
BioSpectrum Asia – Proteomics launches diagnostic test leader ‘PromarkerD’
20/03/2018
Business News Asia – PromarkerD Diagnostic Test Leader Officially Launched
20/03/2018
ACN Newswire – PromarkerD Diagnostic Test Leader Officially Launched
20/03/2018
Silicon Investor – PromarkerD Diagnostic Test Leader Officially Launched
19/03/2018
Bloomberg – PromarkerD Diagnostic Test Leader Officially Launched
07/03/2018
Proteomics launches PromarkerD
12/02/2018
GenomeWeb – Proteomics International Investing in CPR Pharma Services
12/02/2018
ACN Newswire – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development
12/02/2018
BioSpace – Proteomics International Announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development
12/02/2018
Sys.Con Media – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services
12/02/2018
ThePharmaLetter – Proteomics buys stake in CPR Pharma
12/02/2018
Business News Asia – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services
12/02/2018
Bloomberg – Proteomics International Alliance and Investment in CPR Pharma
02/02/2018
Proteomics International India Trade Visit: 19th – 23rd Feb 2018
02/02/2018
Strategic alliance and investment in CPR Pharma Services
31/01/2018
January Newsletter 2018
29/01/2018
PromarkerD diabetic kidney disease patent granted in Japan
Newsroom
News Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Subscribe
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Comments
This field is for validation purposes and should be left unchanged.
Company
About Us
Mission Statement
Senior Staff
Board of Directors
Clinical Advisory Board
Customer Testimonials
Quality Control
Careers
Glossary
Promarker™ Pipeline
PromarkerD
PromarkerEndo
PromarkerEso
OxiDx
Project Statuses
Biomarker Discovery
Analytical Services
Pharmacokinetics
Biomarker Services
Protein Analysis
Project Consultation
Pricing and Ordering – Commercial
Pricing and Ordering - Local WAP
Downloads
Terms and Conditions
FAQs
Newsroom
News & Media
Newsletters
Publications
Events and Presentations
Investors
ASX Announcements
Share Price and Analyst Coverage
Library
Reports
Corporate Governance
Shareholder Information
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Agents